These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18504423)

  • 41. Polymorphisms of the glucocorticoid receptor gene and major depression.
    van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
    Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.
    Shi Y; Yuan Y; Xu Z; Pu M; Wang C; Zhang Y; Liu Z; Wang C; Li L; Zhang Z
    J Affect Disord; 2012 Feb; 136(3):558-66. PubMed ID: 22119081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor replication of candidate genes for major depressive disorder using genome-wide association data.
    Bosker FJ; Hartman CA; Nolte IM; Prins BP; Terpstra P; Posthuma D; van Veen T; Willemsen G; DeRijk RH; de Geus EJ; Hoogendijk WJ; Sullivan PF; Penninx BW; Boomsma DI; Snieder H; Nolen WA
    Mol Psychiatry; 2011 May; 16(5):516-32. PubMed ID: 20351714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
    Schuhmacher A; Mössner R; Höfels S; Pfeiffer U; Guttenthaler V; Wagner M; Schwab SG; Maier W; Zobel A
    Int J Neuropsychopharmacol; 2011 Mar; 14(2):237-45. PubMed ID: 20701824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene × environment interactions in the prediction of response to antidepressant treatment.
    Klengel T; Binder EB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.
    Traks T; Koido K; Eller T; Maron E; Kingo K; Vasar V; Vasar E; Kõks S
    BMC Med Genet; 2008 Dec; 9():111. PubMed ID: 19087313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis.
    Zhao X; Song C; Wang N; He J; Yang X; Zhang H; Deng Y; He Y; Liu Y; Li H; Cao S
    Psychiatr Genet; 2020 Aug; 30(4):101-109. PubMed ID: 32459709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catechol-O-methyltransferase (COMT) pharmacogenetics in the treatment response phenotypes of major depressive disorder (MDD).
    Kocabas NA
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):264-72. PubMed ID: 22483292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.
    Arias B; Fabbri C; Serretti A; Drago A; Mitjans M; Gastó C; Catalán R; Fañanás L
    J Affect Disord; 2014 Oct; 168():91-7. PubMed ID: 25043320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population.
    Mahmood S; Evinová A; Škereňová M; Ondrejka I; Lehotský J
    Cent Eur J Public Health; 2016 Sep; 24(3):223-230. PubMed ID: 27755861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
    Millard SJ; Weston-Green K; Newell KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoid receptor polymorphisms in major depression.
    Claes S
    Ann N Y Acad Sci; 2009 Oct; 1179():216-28. PubMed ID: 19906242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
    Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
    J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
    Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R
    Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroimmunology of depression.
    Sarno E; Moeser AJ; Robison AJ
    Adv Pharmacol; 2021; 91():259-292. PubMed ID: 34099111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder.
    Luo X; Stavrakakis N; Penninx BW; Bosker FJ; Nolen WA; Boomsma DI; de Geus EJ; Smit JH; Snieder H; Nolte IM; Hartman CA
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):215-36. PubMed ID: 26566975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
    Postolache TT; Del Bosque-Plata L; Jabbour S; Vergare M; Wu R; Gragnoli C
    Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):186-203. PubMed ID: 30729689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.
    Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
    Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
    Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.